Elise S. Burger
( out of 55 reviews )

Elise S. Burger, MD, PhD

Languages spoken: English

Clinical Locations

Midvalley Health Center

Dermatology
Murray
801-581-2955

Primary Children's Hospital

Pediatric Dermatology
Salt Lake City
801-662-1603

University of Utah Hospital

Dermatology, Area E
Salt Lake City
801-581-2955

  • Specialties

    Board Certification

    American Board of Dermatology
    National Board of Medical Examiners

    Patient Rating

    5.0 /5
    ( out of 55 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

  • Board Certification and Academic Information

    Academic Departments Dermatology -Primary
    Board Certification
    American Board of Dermatology
    National Board of Medical Examiners

    Education history

    Chief Resident Dermatology - University of California, San Diego School of Medicine Chief Resident
    Dermatology - University of California, San Diego School of Medicine Resident
    Internship Presbyterian/St. Luke's Medical Center Transitional Internship
    Immunology - University of Texas Southwestern Medical Center Ph.D.
    Professional Medical Medicine - University of Texas Southwestern Medical Center M.D.
    Biochemistry - Occidental College B.A.

    Selected Publications

    Journal Article

    1. Burger E, Hinds B, Paravar T (2023). Progressively worsening painful sclerotic calf plaques. JAAD Case Rep, 34, 94-96. (Read full article)
    2. Burger E, Gallo RL (2022). Host-microbiome interactions in the holobiome of atopic dermatitis. J Allergy Clin Immunol. (Read full article)
    3. Kellogg C, Burger E, Hinds BR, Schneider JA (2022). Angioinvasive Alternaria alternata presenting with violaceous papules and plaques in the setting of chronic lymphocytic leukemia. JAAD Case Rep, 31, 6-9. (Read full article)
    4. Araujo A, Safronova A, Burger E, Lpez-Yglesias A, Giri S, Camanzo ET, Martin AT, Grivennikov S, Yarovinsky F (2021). IFN-γ mediates Paneth cell death via suppression of mTOR. Elife, 10. (Read full article)
    5. Lpez-Yglesias AH, Burger E, Camanzo E, Martin AT, Araujo AM, Kwok SF, Yarovinsky F (2021). T-bet-dependent ILC1- and NK cell-derived IFN-γ mediates cDC1-dependent host resistance against Toxoplasma gondii. PLoS Pathog, 17(1), e1008299. (Read full article)
    6. Lpez-Yglesias AH, Burger E, Araujo A, Martin AT, Yarovinsky F (2018). T-bet-independent Th1 response induces intestinal immunopathology during Toxoplasma gondii infection. Mucosal Immunol, 11(3), 921-931. (Read full article)
    7. Burger E, Araujo A, Lpez-Yglesias A, Rajala MW, Geng L, Levine B, Hooper LV, Burstein E, Yarovinsky F (2018). Loss of Paneth Cell Autophagy Causes Acute Susceptibility to Toxoplasma gondii-Mediated Inflammation. Cell Host Microbe, 23(2), 177-190.e4. (Read full article)
    8. Sturge CR, Burger E, Raetz M, Hooper LV, Yarovinsky F (2015). Cutting Edge: Developmental Regulation of IFN-γ Production by Mouse Neutrophil Precursor Cells. J Immunol, 195(1), 36-40. (Read full article)

  • News & Podcasts